HAIM
PFE icon

Hunter Associates Investment Management’s Pfizer PFE Stock Holding History

Hunter Associates Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
104,837
+1,028
+1% +$26.9K 0.29% 77
2026
Q1 		$2.92M Sell
103,809
-15,614
-13% -$416K 0.39% 62
2025
Q4 		$2.97M Sell
119,423
-1,737
-1% -$43.8K 0.4% 55
2025
Q3 		$3.08M Buy
121,160
+13
+0% +$321 0.43% 52
2025
Q2 		$2.94M Sell
121,147
-337
-0.3% -$7.86K 0.44% 54
2025
Q1 		$3.08M Sell
121,484
-492
-0.4% -$12.9K 0.47% 50
2024
Q4 		$3.24M Sell
121,976
-13,796
-10% -$374K 0.49% 46
2024
Q3 		$3.93M Sell
135,772
-627
-0.5% -$18.3K 0.61% 35
2024
Q2 		$3.82M Sell
136,399
-742
-0.5% -$20.4K 0.64% 36
2024
Q1 		$3.81M Sell
137,141
-2,860
-2% -$79.4K 0.64% 34
2023
Q4 		$4.03M Sell
140,001
-2,063
-1% -$62.4K 0.74% 33
2023
Q3 		$4.71M Sell
142,064
-1,792
-1% -$63.4K 0.96% 27
2023
Q2 		$5.28M Sell
143,856
-227
-0.2% -$8.84K 1.03% 24
2023
Q1 		$5.88M Buy
144,083
+548
+0.4% +$23.7K 1.26% 20
2022
Q4 		$7.35M Sell
143,535
-972
-0.7% -$46.6K 1.77% 13
2022
Q3 		$6.33M Sell
144,507
-23
-0% -$1.12K 1.64% 15
2022
Q2 		$7.58M Buy
144,530
+26,896
+23% +$1.37M 1.87% 14
2022
Q1 		$6.09M Hold
117,634
– – 1.96% 13
2021
Q4 		$6.95M Hold
117,634
– – 1.99% 13
2021
Q3 		$5.06M Hold
117,634
– – 1.63% 16
2021
Q2 		$4.61M Sell
117,634
-36,183
-24% -$1.41M 1.43% 19
2021
Q1 		$5.57M Buy
153,817
+4,985
+3% +$177K 1.29% 23
2020
Q4 		$5.48M Sell
148,832
-8,239
-5% -$302K 1.35% 21
2020
Q3 		$5.47M Sell
157,071
-837
-0.5% -$29.3K 1.52% 19
2020
Q2 		$4.9M Sell
157,908
-194
-0.1% -$6.59K 1.46% 21
2020
Q1 		$4.9M Buy
158,102
+771
+0.5% +$26.3K 1.9% 18
2019
Q4 		$5.85M Sell
157,331
-1,086
-0.7% -$38.7K 1.82% 16
2019
Q3 		$5.4M Buy
158,417
+111
+0.1% +$4.04K 1.86% 17
2019
Q2 		$6.51M Sell
158,306
-310
-0.2% -$12.3K 2.24% 13
2019
Q1 		$6.39M Sell
158,616
-628
-0.4% -$25.1K 2.24% 13
2018
Q4 		$6.59M Sell
159,244
-2,673
-2% -$111K 2.68% 9
2018
Q3 		$6.77M Sell
161,917
-205
-0.1% -$7.89K 2.33% 12
2018
Q2 		$5.58M Sell
162,122
-1,589
-1% -$54.3K 2.02% 14
2018
Q1 		$5.51M Buy
163,711
+1,375
+0.8% +$47.3K 2.06% 14
2017
Q4 		$5.58M Buy
162,336
+495
+0.3% +$16.9K 2.06% 14
2017
Q3 		$5.48M Sell
161,841
-99
-0.1% -$3.18K 2.14% 12
2017
Q2 		$5.16M Sell
161,940
-295
-0.2% -$9.3K 2.1% 13
2017
Q1 		$5.27M Sell
162,235
-45,865
-22% -$1.45M 2.22% 10
2016
Q4 		$6.41M Buy
208,100
+45,138
+28% +$1.38M 2.74% 7
2016
Q3 		$5.24M Sell
162,962
-5,956
-4% -$199K 2.25% 7
2016
Q2 		$5.64M Buy
168,918
+3,338
+2% +$107K 2.44% 8
2016
Q1 		$4.66M Sell
165,580
-100
-0.1% -$2.86K 2.13% 13
2015
Q4 		$5.07M Sell
165,680
-941
-0.6% -$29.6K 2.23% 10
2015
Q3 		$4.96M Sell
166,621
-944
-0.6% -$30.3K 2.33% 11
2015
Q2 		$5.33M Sell
167,565
-581
-0.3% -$18.9K 2.22% 9
2015
Q1 		$5.55M Buy
168,146
+742
+0.4% +$23.6K 2.19% 10
2014
Q4 		$4.95M Sell
167,404
-986
-0.6% -$28.3K 1.9% 13
2014
Q3 		$4.72M Sell
168,390
-575
-0.3% -$16.1K 1.84% 13
2014
Q2 		$4.76M Buy
168,965
+1,776
+1% +$50.6K 1.87% 12
2014
Q1 		$5.09M Sell
167,189
-2,424
-1% -$72.3K 2.01% 9
2013
Q4 		$4.93M Sell
169,613
-5,639
-3% -$164K 1.9% 11
2013
Q3 		$4.78M Sell
175,252
-21,692
-11% -$590K 1.99% 11
2013
Q2 		$5.23M Buy
+196,944
New +$5.44M 1.94% 11

Other funds holding PFE

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Hunter Associates Investment Management's PFE Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Pfizer (PFE) stake by 0.99% in Q2 2026, buying an estimated $26.9K and bringing the position to 104,837 shares worth $2.52M. The position accounts for 0.29% of the portfolio, ranked #77.

Hunter Associates Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.58M in Q2 2022. 1,384 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hunter Associates Investment Management held 104,837 shares of Pfizer worth $2.52M as of Q2 2026.
  • Hunter Associates Investment Management bought 1,028 Pfizer shares in Q2 2026, an estimated $26.9K.
  • Pfizer made up 0.29% of Hunter Associates Investment Management's portfolio in Q2 2026, its #77 holding.
  • Hunter Associates Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Hunter Associates Investment Management's Pfizer position peaked at $7.58M in Q2 2022.
  • 1,384 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.